US insurance giant Cigna has taken fresh legal action against Bristol Myers Squibb (NYSE: BMY), accusing the drugmaker of ...

Bristol Myers and Celgene are being sued in an antitrust suit, alleging they used fraud, sham litigation, and reverse ...

Two months after Bristol Myers Squibb fended off a lawsuit which accused the drugmaker of using illegal tactics to protect ...

Cigna sued Bristol Myers Squibb on Tuesday, accusing the drugmaker of violating U.S. antitrust law by keeping generic ...

Cigna (NYSE:CI) on Tuesday filed an antitrust lawsuit accusing Bristol Myers Squibb (NYSE:BMY) of breaching U.S. competition ...

Cigna sued Bristol Myers Squibb on Tuesday, accusing the drugmaker of violating U.S. antitrust law by keeping generic ...

BMY's banks on label expansion of drugs like Sotyktu and Opdivo to boost sales in the wake of generic competition for legacy drugs.

BMY depends on label expansion of approved drugs and approval of new drugs to stabilize its revenue base as its legacy drugs (Revlimid, Pomalyst, Sprycel and Abraxane) face generic competition.

GSK is putting the finishing touches on its case for antibody-drug conjugate Blenrep with a key progression-free survival (PFS) readout ahead of its potential U.S. | GSK's multiple myeloma antibody ...

In IRAKLIA, 531 patients with relapsed/refractory multiple myeloma were enrolled and randomized 1:1 to be treated with a combination of fixed-dose subcutaneous (SC) or intravenous (IV) isatuximab ...

The World Bank said on Thursday it would resume funding to Uganda, nearly two years after the global lender suspended new financing to the country in response to an anti-LGBT law that imposes ...